Literature DB >> 11737194

Interleukin-6-induced proliferation of pre-B cells mediated by receptor complexes lacking the SHP2/SOCS3 recruitment sites revisited.

K Friederichs1, J Schmitz, M Weissenbach, P C Heinrich, F Schaper.   

Abstract

Interleukin-6 (IL-6) induces B-cell proliferation by binding to receptor complexes composed of a specific alpha-receptor (gp80; CD126) and the signal transducing receptor subunit gp130 (CD130). Immediately after receptor complex activation, signal transducers and activators of transcription (STATs) 1 and 3 and the Src-homology domain-containing protein tyrosine phosphatase 2 (SHP2) are recruited to gp130 and subsequently tyrosine phosphorylated. The activated dimerized STATs translocate to the nucleus and bind to enhancer elements of IL-6-inducible genes. SHP2 acts as an adapter and links the Jak/STAT pathway to the Ras/Raf/MAPK cascade but it is also involved in signal attenuation. Whereas STAT3 activation appears to be crucial for all biological activities of IL-6, the requirement of SHP2-activation depends on the individual biological response analyzed. The requirement of SHP2 activation for the pre-B cell (Ba/F3) proliferation has been reported previously [Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K. & Hirano, T. (1996) Immunity 5, 449-460]. In contrast, we have recently demonstrated that the presence of a single STAT-recruitment site within gp130 is sufficient for IL-6- induced proliferation of Ba/F3 cells [Schmitz, J., Dahmen, H., Grimm, C., Gendo, C., Müller-Newen, G., Heinrich, P.C. & Schaper, F. (2000) J. Immunol. 164, 848-854]. To unravel this discrepancy we analyzed the IL-6-induced dose-dependent proliferation of Ba/F3 cells mediated by receptor complexes lacking SHP2/SOCS3 recruitment sites. Surprisingly, pre-B cells, after stimulation with low amounts of IL-6, proliferate much more efficiently in the absence of the activated SHP2 than in the presence of the tyrosine phosphatase. Therefore, SHP2 activation appears to be relevant for IL-6-induced proliferation only after stimulation with very large amounts of IL-6.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737194     DOI: 10.1046/j.0014-2956.2001.02586.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Sudden appearance and spontaneous regression of diffuse large B cell lymphoma in a man with a broken arm.

Authors:  Peter A Engel; Ching Lee
Journal:  BMJ Case Rep       Date:  2009-03-05

2.  The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.

Authors:  Paul Baran; Selina Hansen; Georg H Waetzig; Mohammad Akbarzadeh; Larissa Lamertz; Heinrich J Huber; M Reza Ahmadian; Jens M Moll; Jürgen Scheller
Journal:  J Biol Chem       Date:  2018-03-20       Impact factor: 5.157

3.  Distinct Differentiation Programs Triggered by IL-6 and LPS in Teleost IgM(+) B Cells in The Absence of Germinal Centers.

Authors:  Beatriz Abós; Tiehui Wang; Rosario Castro; Aitor G Granja; Esther Leal; Jeffrey Havixbeck; Alfonso Luque; Daniel R Barreda; Chris J Secombes; Carolina Tafalla
Journal:  Sci Rep       Date:  2016-08-02       Impact factor: 4.379

4.  Immunomodulatory effect of mesenchymal stem cells on B cells.

Authors:  Marcella Franquesa; M J Hoogduijn; O Bestard; J M Grinyó
Journal:  Front Immunol       Date:  2012-07-20       Impact factor: 7.561

5.  New insights into the Shwachman-Diamond Syndrome-related haematological disorder: hyper-activation of mTOR and STAT3 in leukocytes.

Authors:  Valentino Bezzerri; Antonio Vella; Elisa Calcaterra; Alessia Finotti; Jessica Gasparello; Roberto Gambari; Baroukh Maurice Assael; Marco Cipolli; Claudio Sorio
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

Review 6.  Signaling pathways and mesenchymal transition in pediatric high-grade glioma.

Authors:  Michaël H Meel; Sophie A Schaper; Gertjan J L Kaspers; Esther Hulleman
Journal:  Cell Mol Life Sci       Date:  2017-11-21       Impact factor: 9.261

Review 7.  The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma.

Authors:  H Dean Hosgood; Marc J Gunter; Neil Murphy; Thomas E Rohan; Howard D Strickler
Journal:  Front Oncol       Date:  2018-04-16       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.